STOCK TITAN

InMode to Participate in Upcoming Investor Conferences

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences

InMode (NASDAQ:INMD), a leading global provider of innovative medical technologies, has announced its participation in two upcoming investor conferences in August 2025. The company will attend the 10th Annual Needham Virtual MedTech & Diagnostics Conference on August 11, where CEO Moshe Mizrahy will conduct virtual one-on-one meetings.

Additionally, CFO Yair Malca will participate in the Canaccord 45th Annual Global Growth Conference in Boston on August 12 at 2:30 pm ET, featuring a fireside chat moderated by Caitlin Cronin and investor meetings. A live webcast of the presentation will be available.

Loading...
Loading translation...

Positive

  • None.

Negative

  • None.

News Market Reaction 1 Alert

+0.43% News Effect

On the day this news was published, INMD gained 0.43%, reflecting a mild positive market reaction.

Data tracked by StockTitan Argus on the day of publication.

YOKNEAM, Israel, Aug. 5, 2025 /PRNewswire/ -- InMode Ltd. (Nasdaq: INMD), a leading global provider of innovative medical technologies, today announced the participation in the following investor conferences in August:

InMode Ltd. Logo

10th Annual Needham Virtual MedTech & Diagnostics Conference

Presenters: Moshe Mizrahy, Chief Executive Officer

Format: Virtual one-on-one meetings

When: Monday, Aug. 11

 

Canaccord 45th Annual Global Growth Conference

Presenters: Yair Malca, Chief Financial Officer

Format: In-person fireside chat moderated by Caitlin Cronin, Director of MedTech Equity Research, and meetings

When: Tuesday, Aug. 12 at 2:30 pm ET

A live webcast of the presentation can be accessed here.

Location: Boston, MA

About InMode

InMode is a leading global provider of innovative medical technologies. InMode develops, manufactures, and markets devices harnessing novel radio frequency ("RF") technology. InMode strives to enable new emerging surgical procedures as well as improve existing treatments. InMode has leveraged its medically accepted minimally invasive RF technologies to offer a comprehensive line of products across several categories for plastic surgery, gynecology, dermatology, otolaryngology, and ophthalmology. For more information about InMode, please visit www.inmodemd.com.

Forward-Looking Statements

The information in this press release includes forward-looking statements within the meaning of the federal securities laws. These statements generally relate to future events or InMode's future financial or operating performance, including the 2025 revenue projection described above. Actual outcomes and results may differ materially from what is expressed or forecast in such forward-looking statements. In some cases, you can identify these statements because they contain words such as "anticipate," "believe," "estimate," "expect," "intend," "may," "plan," "predict," "project," "will," "would" and similar expressions that concern our expectations, strategic plans or intentions. Forward-looking statements are based on management's current expectations and assumptions, and are subject to inherent uncertainties, risks and changes in circumstances that are difficult to predict. Consequently, actual results could differ materially from those indicated in these forward-looking statements. When considering these forward-looking statements, you should keep in mind the risk factors and other cautionary statements included in InMode's Annual Report on Form 20-F filed with the Securities and Exchange Commission on February 04, 2025, and our future public filings. InMode undertakes no obligation and does not intend to update these forward-looking statements to reflect events or circumstances occurring after this press release. You are cautioned not to place undue reliance on these forward-looking statements, which pertain only as of the date of this press release.

Investor Relations Contact:

Miri Segal-Scharia

MS-IR LLC

ir@inmodemd.com

Logo - https://mma.prnewswire.com/media/1064477/InMode_Logo.jpg

Cision View original content:https://www.prnewswire.com/news-releases/inmode-to-participate-in-upcoming-investor-conferences-302520988.html

SOURCE InMode Ltd.

FAQ

When is InMode (INMD) presenting at the Canaccord Global Growth Conference 2025?

InMode will present at the Canaccord Conference on Tuesday, August 12, 2025 at 2:30 pm ET in Boston, MA.

Who will represent InMode at the Needham Virtual MedTech Conference 2025?

Moshe Mizrahy, InMode's Chief Executive Officer, will represent the company conducting virtual one-on-one meetings.

How can investors access InMode's presentation at the Canaccord Conference?

Investors can access the presentation through a live webcast available through the provided link.

What type of session will InMode have at the Canaccord Conference 2025?

InMode will participate in a fireside chat moderated by Caitlin Cronin, Director of MedTech Equity Research, along with investor meetings.
Inmode Ltd.

NASDAQ:INMD

INMD Rankings

INMD Latest News

INMD Latest SEC Filings

INMD Stock Data

912.11M
56.48M
15.35%
59.25%
5.46%
Medical Devices
Healthcare
Link
Israel
Yokne'am